WASHINGTON, DC–Congressman Neal Dunn, M.D. (FL-02) and Congressman Darren Soto (FL-09) have introduced the Facilitating Access to Innovation in Cancer Care Act (FAIC Act) to ensure cancer patients on Medicare can access the most effective treatments available.
Recent breakthroughs in cancer care have produced innovative therapies that improve patient outcomes while reducing long-term healthcare costs. However, flaws in Medicare’s current payment structure have prevented many of these treatments from reaching patients, instead favoring older, less effective options. The FAIC Act addresses this issue by requiring Medicare to reimburse certain cancer drugs separately, rather than bundling them into procedure payments that discourage their use.
CMS has acknowledged for years that bundled payment policies can restrict access to necessary treatments. While the agency took steps in 2025 to reverse this policy for certain diagnostic drugs, it has not extended the fix to cancer therapies. The FAIC Act would correct this gap by ensuring these medications are reimbursed appropriately under Medicare Part B.
Importantly, the legislation is budget-neutral under Medicare’s outpatient payment system.
“As a physician, I have seen firsthand the impact that innovation can have on patient outcomes,”said Congressman Dunn.“This bill ensures Medicare keeps pace with innovation so patients can receive the most effective care. By addressing this issue, we can improve outcomes, reduce recurrence, and ultimately lower costs for patients and taxpayers alike.”
“I am honored to work with Dr. Dunn on this effort to ensure Medicare beneficiaries have access to cancer treatments and diagnostics,”said Rep. Soto. “Cancer patients are a uniquely vulnerable population, and equitable access to treatments regardless of insurance coverage is critical to ensuring their cancer does not spread or return."
